H. Nalçacıoğlu Et Al. , "Efficacy of anakinra in a patient with systemic amyloidosis presenting as amyloidoma," INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , vol.21, no.2, pp.552-559, 2018
Nalçacıoğlu, H. Et Al. 2018. Efficacy of anakinra in a patient with systemic amyloidosis presenting as amyloidoma. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , vol.21, no.2 , 552-559.
Nalçacıoğlu, H., Ozkaya, O., Genc, G., Ayyildiz, S., Kefeli, M., Elli, M., ... Aydin, O.(2018). Efficacy of anakinra in a patient with systemic amyloidosis presenting as amyloidoma. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , vol.21, no.2, 552-559.
Nalçacıoğlu, Hülya Et Al. "Efficacy of anakinra in a patient with systemic amyloidosis presenting as amyloidoma," INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , vol.21, no.2, 552-559, 2018
Nalçacıoğlu, Hülya Et Al. "Efficacy of anakinra in a patient with systemic amyloidosis presenting as amyloidoma." INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , vol.21, no.2, pp.552-559, 2018
Nalçacıoğlu, H. Et Al. (2018) . "Efficacy of anakinra in a patient with systemic amyloidosis presenting as amyloidoma." INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , vol.21, no.2, pp.552-559.
@article{article, author={Hülya Nalçacıoğlu Et Al. }, title={Efficacy of anakinra in a patient with systemic amyloidosis presenting as amyloidoma}, journal={INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES}, year=2018, pages={552-559} }